Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Becton to sell Clontech to Takara Bio:

This article was originally published in Clinica

Executive Summary

Becton Dickinson has agreed to sell its Mountain View, California-based Clontech business, which makes biological products for the life science market as part of the group's BD Biosciences division, to Takara Bio, of Otsu, Japan. Becton Dickinson announced its intention to sell the Mountain View, California business in October 2004. Takara Bio will pay $60m, or about the same as Clontech's fiscal 2004 revenues. The transaction is expected to close by August 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055669

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel